SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-21-002454
Filing Date
2021-04-13
Accepted
2021-04-13 16:11:30
Documents
4
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A def14a_033121.htm DEF 14A 898855
2 GRAPHIC logo.jpg GRAPHIC 10619
3 GRAPHIC pcard_1.jpg GRAPHIC 197826
4 GRAPHIC pcard_2.jpg GRAPHIC 104220
  Complete submission text file 0001171843-21-002454.txt   1325457
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 21823193
SIC: 2836 Biological Products, (No Diagnostic Substances)